Henry Li1, Pelicia Lim1,2, Edward Stanley1, Geoffrey Lee1,2, Sandra Lin1, Derek Neoh1,2, Julian Liew1,3, Sally Kiu-Huen Ng1,2,4. 1. Department of Plastic and Reconstructive Surgery, Austin Health, Heidelberg, Victoria, Australia. 2. Department of Plastic and Reconstructive Surgery, Maroondah Hospital, Ringwood East, Victoria, Australia. 3. Department of Plastic and Reconstructive Surgery, Northern Hospital, Epping, Victoria, Australia. 4. Department of Plastic and Reconstructive Surgery, Western Health, St Albans, Victoria, Australia.
Abstract
BACKGROUND: The NovoSorb® Biodegradable Temporising Matrix (BTM) is a synthetic polyurethane dermal matrix used to reconstruct complex wounds including deep dermal and full-thickness burns, necrotising fasciitis and free flap donor site. We hope to further explore its potential applications in this series. METHODS: Patients who received BTM application across four centres over an 18-month period were included. Patients were followed up to assess BTM and graft take, the aesthetic, the return of sensation and complications. RESULTS: A total of 27 patients with 35 wounds were identified with a range of aetiologies. Thirty-three wounds had 100% integration of BTM at the time of sealing membrane removal. Seven wounds had partial graft loss that later healed by secondary intention. In two cases, re-epithelialisation occurred with BTM alone without split-skin graft. CONCLUSION: BTM offers a safe and reliable reconstructive option in challenging wounds that would otherwise require more complex operations.
BACKGROUND: The NovoSorb® Biodegradable Temporising Matrix (BTM) is a synthetic polyurethane dermal matrix used to reconstruct complex wounds including deep dermal and full-thickness burns, necrotising fasciitis and free flap donor site. We hope to further explore its potential applications in this series. METHODS:Patients who received BTM application across four centres over an 18-month period were included. Patients were followed up to assess BTM and graft take, the aesthetic, the return of sensation and complications. RESULTS: A total of 27 patients with 35 wounds were identified with a range of aetiologies. Thirty-three wounds had 100% integration of BTM at the time of sealing membrane removal. Seven wounds had partial graft loss that later healed by secondary intention. In two cases, re-epithelialisation occurred with BTM alone without split-skin graft. CONCLUSION:BTM offers a safe and reliable reconstructive option in challenging wounds that would otherwise require more complex operations.
Authors: David Breidung; Panagiotis Fikatas; Patrick Mandal; Maresa D Berns; Andrè A Barth; Moritz Billner; Ioannis-Fivos Megas; Bert Reichert Journal: Healthcare (Basel) Date: 2022-04-30